• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞壁蛋白2作为候选疫苗可保护小鼠免受感染。

Cell Wall Protein 2 as a Vaccine Candidate Protects Mice Against Infection.

作者信息

Wang Shaohui, Heuler Joshua, Bullock Jessica, Qin Junling, Chakraborty Soumyadeep, Nathaniel Agbendeh Lubem, Wang Shifeng, Sun Xingmin

机构信息

Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33620, USA.

Department of Chemistry, University of South Florida, Tampa, FL 33620, USA.

出版信息

Vaccines (Basel). 2024 Dec 30;13(1):21. doi: 10.3390/vaccines13010021.

DOI:10.3390/vaccines13010021
PMID:39852800
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11768939/
Abstract

BACKGROUND/OBJECTIVES: is a Gram-positive, spore-forming enteric pathogen that causes intestinal disorders, including inflammation and diarrhea, primarily through toxin production. Standard treatment options for infection (CDI) involve a limited selection of antibiotics that are not fully effective, leading to high recurrence rates. Vaccination presents a promising strategy for preventing both CDI and its recurrence. Cell wall protein 2 (Cwp2), a highly immunogenic and abundant surface-exposed cell wall protein, plays an important role in the bacterium's adherence in vitro. In this study, we aimed to analyze the homology and immunogenicity of Cwp2 and its protection efficacy as a vaccine candidate against CDI in mice.

METHODS

we conducted in silico analyses to assess the homology and immunogenicity of Cwp2, and we evaluated its potential as a vaccine candidate against CDI using a mouse model of immunization and infection.

RESULTS

Our in silico analyses predicted the immunogenic region (functional domain) of Cwp2 and revealed its high homology among various toxinotypes and ribotypes (R.T.s) or sequence types (S.T.s). Immunizations of mice with the Cwp2 functional domain (Cwp2_A) induced potent IgG/A antibody responses against Cwp2_A, protected mice from CDI, and reduced spore and toxin levels in feces post-infection. Additionally, anti-Cwp2_A sera inhibited the binding of vegetative cells to HCT8 cells.

CONCLUSIONS

Our report demonstrates for the first time the potential of Cwp2_A as an effective vaccine candidate against CDI in mice.

摘要

背景/目的:艰难梭菌是一种革兰氏阳性、产芽孢的肠道病原体,主要通过产生毒素引发肠道疾病,包括炎症和腹泻。艰难梭菌感染(CDI)的标准治疗方案所涉及的抗生素选择有限且效果不完全理想,导致复发率很高。疫苗接种是预防CDI及其复发的一种有前景的策略。细胞壁蛋白2(Cwp2)是一种高度免疫原性且大量暴露于表面的细胞壁蛋白,在该细菌的体外黏附中起重要作用。在本研究中,我们旨在分析Cwp2的同源性和免疫原性,以及其作为抗CDI疫苗候选物在小鼠中的保护效果。

方法

我们进行了计算机分析以评估Cwp2的同源性和免疫原性,并使用免疫和感染小鼠模型评估其作为抗CDI疫苗候选物的潜力。

结果

我们的计算机分析预测了Cwp2的免疫原性区域(功能域),并揭示了其在各种毒素型和核糖体分型(R.T.s)或序列分型(S.T.s)之间的高度同源性。用Cwp2功能域(Cwp2_A)免疫小鼠可诱导针对Cwp2_A的强效IgG/A抗体反应,保护小鼠免受CDI感染,并降低感染后粪便中的芽孢和毒素水平。此外,抗Cwp2_A血清可抑制营养细胞与HCT8细胞的结合。

结论

我们的报告首次证明了Cwp2_A作为抗小鼠CDI有效疫苗候选物的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f1/11768939/cbadfaa3757d/vaccines-13-00021-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f1/11768939/d6f01ed5da92/vaccines-13-00021-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f1/11768939/7af361a44181/vaccines-13-00021-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f1/11768939/0cad0d018708/vaccines-13-00021-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f1/11768939/e1eb7e9fa7a5/vaccines-13-00021-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f1/11768939/b4fd92bdd45c/vaccines-13-00021-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f1/11768939/35b37a407f9c/vaccines-13-00021-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f1/11768939/ba38dde0f0b9/vaccines-13-00021-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f1/11768939/aa80c72b4f95/vaccines-13-00021-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f1/11768939/cbadfaa3757d/vaccines-13-00021-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f1/11768939/d6f01ed5da92/vaccines-13-00021-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f1/11768939/7af361a44181/vaccines-13-00021-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f1/11768939/0cad0d018708/vaccines-13-00021-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f1/11768939/e1eb7e9fa7a5/vaccines-13-00021-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f1/11768939/b4fd92bdd45c/vaccines-13-00021-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f1/11768939/35b37a407f9c/vaccines-13-00021-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f1/11768939/ba38dde0f0b9/vaccines-13-00021-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f1/11768939/aa80c72b4f95/vaccines-13-00021-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9f1/11768939/cbadfaa3757d/vaccines-13-00021-g009.jpg

相似文献

1
Cell Wall Protein 2 as a Vaccine Candidate Protects Mice Against Infection.细胞壁蛋白2作为候选疫苗可保护小鼠免受感染。
Vaccines (Basel). 2024 Dec 30;13(1):21. doi: 10.3390/vaccines13010021.
2
Development of an Effective Nontoxigenic Clostridioides difficile-Based Oral Vaccine against C. difficile Infection.开发一种有效的无细胞毒素艰难梭菌口服疫苗以预防艰难梭菌感染。
Microbiol Spectr. 2022 Jun 29;10(3):e0026322. doi: 10.1128/spectrum.00263-22. Epub 2022 May 18.
3
Recombinant Fusion Protein Vaccine Containing Clostridioides difficile FliC and FliD Protects Mice against C. difficile Infection.含艰难梭菌 FliC 和 FliD 的重组融合蛋白疫苗可保护小鼠免受艰难梭菌感染。
Infect Immun. 2023 Apr 18;91(4):e0016922. doi: 10.1128/iai.00169-22. Epub 2023 Mar 20.
4
Genomic and Phenotypic Characterization of the Nontoxigenic Clostridioides difficile Strain CCUG37785 and Demonstration of Its Therapeutic Potential for the Prevention of C. difficile Infection.非产毒艰难梭菌 CCUG37785 株的基因组和表型特征及其预防艰难梭菌感染的治疗潜力的研究
Microbiol Spectr. 2022 Apr 27;10(2):e0178821. doi: 10.1128/spectrum.01788-21. Epub 2022 Mar 22.
5
Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.两组分艰难梭菌类毒素疫苗诱导的系统抗体应答可预防仓鼠艰难梭菌相关性疾病。
J Med Microbiol. 2013 Sep;62(Pt 9):1394-1404. doi: 10.1099/jmm.0.056796-0. Epub 2013 Mar 21.
6
Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against infection challenge .新型非定殖单菌株活生物治疗产品ADS024可预防感染挑战。
World J Gastrointest Pathophysiol. 2023 Aug 24;14(4):71-85. doi: 10.4291/wjgp.v14.i4.71.
7
The microbial metabolite urolithin A reduces toxin expression and toxin-induced epithelial damage.微生物代谢产物尿石素A可降低毒素表达及毒素诱导的上皮损伤。
mSystems. 2024 Feb 20;9(2):e0125523. doi: 10.1128/msystems.01255-23. Epub 2024 Jan 9.
8
Antimicrobial Activity of Tannic Acid and Its Protective Effect on Mice against Clostridioides difficile.没食子酸的抗菌活性及其对艰难梭菌感染小鼠的保护作用。
Microbiol Spectr. 2023 Feb 14;11(1):e0261822. doi: 10.1128/spectrum.02618-22. Epub 2022 Dec 20.
9
Oral teicoplanin administration suppresses recurrence of Clostridioides difficile infection: Proof of concept.口服替考拉宁可抑制艰难梭菌感染的复发:概念验证。
Anaerobe. 2023 Dec;84:102789. doi: 10.1016/j.anaerobe.2023.102789. Epub 2023 Oct 23.
10
The role of the gut microbiome in colonization resistance and recurrent infection.肠道微生物群在定植抗性和反复感染中的作用。
Therap Adv Gastroenterol. 2022 Nov 18;15:17562848221134396. doi: 10.1177/17562848221134396. eCollection 2022.

本文引用的文献

1
A novel monoclonal antibody against 6-sulfo sialyl Lewis x glycans attenuates murine allergic rhinitis by suppressing Th2 immune responses.一种新型抗 6-硫酸唾液酸路易斯 X 聚糖的单克隆抗体通过抑制 Th2 免疫应答来减轻小鼠变应性鼻炎。
Sci Rep. 2023 Sep 21;13(1):15740. doi: 10.1038/s41598-023-43017-w.
2
Aluminum Adjuvants-'Back to the Future'.铝佐剂——“回到未来”
Pharmaceutics. 2023 Jul 4;15(7):1884. doi: 10.3390/pharmaceutics15071884.
3
Mucosal Vaccination Strategies against Infection.针对感染的黏膜疫苗接种策略
Vaccines (Basel). 2023 Apr 23;11(5):887. doi: 10.3390/vaccines11050887.
4
Recombinant Fusion Protein Vaccine Containing Clostridioides difficile FliC and FliD Protects Mice against C. difficile Infection.含艰难梭菌 FliC 和 FliD 的重组融合蛋白疫苗可保护小鼠免受艰难梭菌感染。
Infect Immun. 2023 Apr 18;91(4):e0016922. doi: 10.1128/iai.00169-22. Epub 2023 Mar 20.
5
Host Immune Responses to Surface S-Layer Proteins (SLPs) of .宿主对……表面S层蛋白(SLPs)的免疫反应
Microorganisms. 2023 Feb 2;11(2):380. doi: 10.3390/microorganisms11020380.
6
Surface layer protein A from hypervirulent Clostridioides difficile ribotypes induce significant changes in the gene expression of tight junctions and inflammatory response in human intestinal epithelial cells.高毒力艰难梭菌核糖型的表层蛋白A可诱导人肠上皮细胞紧密连接的基因表达和炎症反应发生显著变化。
BMC Microbiol. 2022 Oct 27;22(1):259. doi: 10.1186/s12866-022-02665-0.
7
An Update on Binary Toxin.二元毒素更新
Toxins (Basel). 2022 Apr 27;14(5):305. doi: 10.3390/toxins14050305.
8
Development of an Effective Nontoxigenic Clostridioides difficile-Based Oral Vaccine against C. difficile Infection.开发一种有效的无细胞毒素艰难梭菌口服疫苗以预防艰难梭菌感染。
Microbiol Spectr. 2022 Jun 29;10(3):e0026322. doi: 10.1128/spectrum.00263-22. Epub 2022 May 18.
9
Structure and assembly of the S-layer in C. difficile.艰难梭菌中 S 层的结构与组装。
Nat Commun. 2022 Feb 25;13(1):970. doi: 10.1038/s41467-022-28196-w.
10
Protein Sequence Analysis Using the MPI Bioinformatics Toolkit.使用 MPI 生物信息学工具包进行蛋白质序列分析。
Curr Protoc Bioinformatics. 2020 Dec;72(1):e108. doi: 10.1002/cpbi.108.